The effects of omeprazole 20 and 40 mg twice daily on intragastric acidity in duodenal ulcer patients

Alimentary Pharmacology and Therapeutics

Volumn 10, Issue 3, 1996, Pages 367-372

  Savarino, V ^a   Mela, G S ^a   Zentilin, P ^a   Mele, M R ^a   Vigneri, S ^b   Mansi, C ^a   Celle, G ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF PALERMO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

OMEPRAZOLE; PLACEBO;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DUODENUM ULCER; FEMALE; HUMAN; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; STOMACH PH;

ADULT; CIRCADIAN RHYTHM; CROSS-OVER STUDIES; DUODENAL ULCER; ENZYME INHIBITORS; FEMALE; GASTRIC ACID; GASTRIC ACIDITY DETERMINATION; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; OMEPRAZOLE; PROTON PUMPS; SINGLE-BLIND METHOD;

EID: 0030011443     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0953-0673.1996.00367.x     Document Type: Article

References (37)

1. Peterson WL. Helicobacter pylori and peptic ulcer disease. N Engl J Med 1991; 324: 1043-8.
2. Ormand JE, Talley NJ. Helicobacter pylori: controversies and approach to management. Mayo Clin Proc 1990;65:414-26.
3. Graham DY, Lew GM, Klein PD, et al. Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric and duodenal ulcer. Ann Intern Med 1992; 116: 705-8.
4. Rauws EAJ, Tytgat GNJ. Cure of duodenal ulcer associated with eradication of Helicobacter pylori. Lancet 1990; ii: 1233-5.
5. Heatley RV. Review article: the treatment of Helicobacter pylori infection. Aliment Pharmacol Ther 1992; 6: 291-303.
6. Chiba N, Rao BV, Rademaker JW, Hunt RH. Meta-analysis of the efficacy of antibiotic therapy in eradicating Helicobacter pylori. Am J Gastroenterol 1992; 87: 1716-27.
7. Bayerdörffer E, Mannes GA, Sommer A, et al. High dose omeprazole treatment combined with amoxicillin eradicated Helicobacter pylori. Eur J Gastroenterol Hepatol 1992; 4: 697-702.
8. Labenz J, Gyenes E, Rühl GH, Börsch G. Amoxicillin plus omeprazole versus triple therapy for eradication of Helicobacter pylori in duodenal ulcer disease: a prospective, randomized, and controlled study. Gut 1993; 34: 1167-70.
9. Adamek RJ, Wegener M, Labenz J, et al. Medium-term results of oral and intravenous omeprazole/amoxicillin Helicobacter pylori eradication therapy. Am J Gastroenterol 1994; 89: 39-42.
10. Logan RPH, Gummett PA, Schanfelberger HD, et al. Eradication of Helicobacter pylori with clarithrmycin and omeprazole. Gut 1994; 35: 323-6.
11. Labenz J, Gyenes E, Rühl GH, Börsch G. Omeprazole plus amoxicillin: efficacy of various treatment regimens to eradicate Helicobacter pylori. Am J Gastroenterol 1993; 88: 491-5.
12. Bayerdörffer E, Miehlke S, Mannes GA, et al. Helicobacter pylori eradication in duodenal ulcer patients with combined high dose omeprazole (120 mg) and amoxicillin treatment. Acta Gastroenterol Belg 1993; 56(Suppl.):130.
13. Lind T, Cederberg C, Ekenved G, Haglund O, Olbe L. Effect of omeprazole - a gastric proton pump inhibitor - on pentagastrin stimulated acid secretion in man. Gut 1983; 24: 270-6.
14. Mela GS, Savarino V, Malesci A, et al. New method for improving accuracy of 24-hour continuous intragastric pH-metry. Reflections on physiological and pharmacological studies. Dig Dis Sci 1994; 39: 1416-24.
15. Mela GS, Savarino V, Moretti M, et al. Antimony and glass pH electrodes can be used interchangeably in 24-hour studies of gastric acidity. Dig Dis Sci 1990; 35: 1473-81.
16. Mela GS, Savarino V, Vigneri S. Optimizing the information obtained from continuous 24-hour gastric pH monitoring. Am J Gastroenterol 1992; 87: 961-6.
17. Mela GS, Savarino V, Moretti M, et al. Clinical relevance of sampling rate in the characterization and analysis of 24-hour gastric acidity. A report in 413 cases. Scand J Gastroenterol 1989; 24: 683-7.
18. Mela GS, Savarino V, Sumberaz A, et al. Continuous acidity monitoring in the study of gastric antisecretory drugs: pH or antilog transformation of pH, mean or median? Am J Gastroenterol 1990; 85: 1105-8.
19. McNulty CAM, Dent JC, Ford GA, Wilkinson JP. Inhibitory antimicrobial concentrations against Campylobacter pylori in gastric mucosa. J Antimicrob Chemother 1988; 22: 729-38.
20. Mela GS, Savarino V, Vigneri S, et al. Limitations of continuous 24-h intragastric pH monitoring in the diagnosis of duodenogastric reflux. Am J Gastroenterol 1995; 90: 933-7.
21. Savarino V, Mela GS, Zentilin P, et al. Variability in individual response to various doses of omeprazole. Implications for antiulcer therapy. Dig Dis Sci 1994; 39: 161-8.
22. Savarino V, Mela GS, Zentilin P, Celle G. Ulcer healing: does omeprazole efficacy depend on daytime or 24-hour acid inhibition? Gastroenterology 1990; 99: 1858-60.
23. Prichard PJ, Yeomans ND, Mihaly GW, et al. Omeprazole: a study of its inhibition of gastric pH and oral pharmacokinetics after morning and evening dosage. Gastroenterology 1985; 88: 64-9.
24. Verdù EF, Armstrong D, Fraser R, et al. Effect of Helicobacter pylori status on intragastric pH during treatment with omeprazole. Gut 1995; 36: 539-43.
25. Verdù EF, Armstrong D, Idström J-P, et al. Effect of curing Helicobacter pylori infection on intragastric pH during treatment with omeprazole. Gut 1995; 37: 743-8.
26. Labenz J, Blum AL, Idström J-P, et al. Augmentation of the antacid effect of omeprazole by Helicobacter pylori infection in duodenal ulcer disease. Gastroenterology 1995; 108: A139.
27. Savarino V, Mela GS, Zentilin P, Vigneri S, Celle G. Acid inhibition and amoxicillin activity against Helicobater pylori. Am J Gastroenterol 1993; 88: 1975-6.
28. Tytat GNJ. Review article: treatments that impact favourably upon the eradication of Helicobacter pylori and ulcer recurrence. Aliment Pharmacol Ther 1994; 8: 359-68.
29. McNulty CAM. Bacteriological and pharmacological basis for the treatment of Campylobacter pylori infection. In: Rathbone BJ, Heatley RV, eds. Campylobacter pylori and Gastroduodenal Disease. Oxford: Blackwell Scientific, 1989: 209-16.
30. Demharter R, Barnert J, Fleischmann R, Wagner T, Wienbeck M. Omeprazole plus amoxicillin in Helicobacter pylori infection: role of gastric pH-metry in predicting successful eradication. Gut 1995; 37(Suppl. 2): A76.
31. Labenz J, Rühl GH, Bertrams J, Börsch G. Medium-or high-dose omeprazole plus amoxicillin eradicates Helicobacter pylori in gastric ulcer disease. Am J Gastroenterol 1994; 89: 726-30.
32. Penston JG. Review article: Helicobacter pylori eradication - understandable caution but not excuse for inertia. Aliment Pharmacol Ther 1994; 8: 369-89.
33. Savarino V, Mela GS, Zentilin P, et al. Antisecretory effects of three omeprazole regimens for maintenance treatment in duodenal ulcer. Dig Dis Sci 1994; 39: 1473-82.
34. Bhatia JJ, Kochar N, Abraham P, Nair NG, Metha AP. Lactobacillus acidophilus inhibits growth of Campylobacter pylori in vitro. J Clin Microbiol 1989; 27: 2328-30.
35. Axon ATR. The role of acid inhibition in the treatment of Helicobacter pylori infection. Scand J Gastroenterol 1994; 29(Suppl. 201): 16-23.
36. Nagata K, Satoh H, Iwahi T, Shimoyama T, Tamura T. Potent inhibitory action of the gastric proton pump inhibitor lansoprazole against urease activity of Helicobacter pylori: unique action selective for H. pylori cells. Antimicrob Agents Chemother 1993; 37: 769-74.
37. McGowan CC, Cover TL, Blaser MJ. The proton pump inhibitor omeprazole inhibits acid survival of Helicobacter pylori by a urease-independent mechanism. Gastroenterology 1994; 107: 738-43.